Author pages are created from data sourced from our academic publisher partnerships and public sources.
Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice.
Abstract Objectives To evaluate the efficacy of tocilizumab (TCZ) in patients with rheumatoid arthritis (RA) in clinical practice, retention rates of the drug and predictors of response. Methods We… Expand
AB0924 Efficacy of subcutaneous ustekinumab therapy in patients with psoriatic arthritis: a single centre-study
Background Ustekinumab is a monoclonal antibody that inhibits IL-12 and 23 that has demonstrated efficacy and safety for the treatment of patients with psoriatic arthritis, plaque psoriasis and… Expand
AB0506 Pregnancy outcomes in women with rheumatic diseases: a single center-study
Background Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS) and Thrombophilia are associated with considerable pregnancy-related morbidity. Multidisciplinary teams allows the… Expand
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology.
Abstract Aims To describe the methodology of REAPSER (Spanish Registry of Recent-onset Psoriatic Arthritis), its strengths and limitations. The aim of this study is to identify prognostic factors for… Expand
AB0760 Efficacy of ustekinumab in a cohort of patients affected by psoriatic arthritis in real-life
Background Psoriatic arthritis (APs) is a chronic inflammatory joint disease, that can be treated effectively with synthetic disease modifying anti-rheumatic drugs (DMARDs) and biological agents.… Expand
AB0580 Congenital heart blockand maternal positive anti-ro and anti-la autoantibodies: a single centre-study
AB0581 Pregnancy outcomes in women with antiphospholipid syndrome and thrombophilia treated in a multidisciplinary unit
Background The Antiphospholipid Syndrome (APS) and Thrombophilia predominantly affect women of fertile age, so their pregnancies should be considered high obstetric risk. These pregnant women need… Expand